INSTANYL

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

fentanyl citrate, Quantity: 0.785 mg/mL (Equivalent: fentanyl, Qty 0.5 mg/mL)

から入手可能:

Takeda Pharmaceuticals Australia Pty Ltd

INN（国際名）:

Fentanyl citrate

医薬品形態:

Spray, nasal

構図:

Excipient Ingredients: monobasic sodium phosphate dihydrate; dibasic sodium phosphate dihydrate; purified water

投与経路:

Nasal

パッケージ内のユニット:

2 bottles per carton, 8 bottles per carton, 6 bottles per carton, 10 bottles per carton

処方タイプ:

(S8) Controlled Drug

適応症:

Instanyl is indicated for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain.

製品概要:

Visual Identification: Nasal spray; Container Type: Bottle, with integral pump - manual actuated; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2013-06-17